IGC

IGC Pharma, Inc.

Pharmaceutical PreparationsNYSENon-accelerated filer<br>Smaller reporting company

Total Trades

1

Buys

1

Sells

0

Largest Trade

$100K–$500K

Insiders

1

Institutional Funds

22

Inst. Value

$500K+

Activist Filings

2

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Moran James PDirectorBUY$100K–$500K588K$0.34Sep 27, 2024
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 22 funds holding

FundShares
RENAISSANCE TECHNOLOGIES LLC920K
BlackRock, Inc.704K
GEODE CAPITAL MANAGEMENT, LLC653K
VANGUARD GROUP INC416K
STATE STREET CORP201K
DEARBORN PARTNERS LLC84K
LAWOOD & CO75K
GOLDMAN SACHS GROUP INC66K
Fisher Asset Management, LLC43K
TRUIST FINANCIAL CORP37K
COMMONWEALTH EQUITY SERVICES, LLC33K
T3 Companies, LLC20K
MORGAN STANLEY18K
GROUP ONE TRADING LLC7K
Geneos Wealth Management Inc.3K
CIBC Private Wealth Group LLC655
Caitlin John, LLC200
UBS Group AG131
Farther Finance Advisors, LLC100
Root Financial Partners, LLC100

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Bradbury Strategic Investment Fund A

SC 13D/A · Aug 14, 2024

18.3%

13.8M shares

Bradbury Strategic Investment Fund A

SC 13D · May 22, 2024

18.3%

13.8M shares

View on Google Finance →